/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. Nucleate Podcast
  2. Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio
Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast · Jun 4, 2026

Q32 Bio CEO Jodie Morrison on leading mission-driven biotechs, navigating challenges, and fostering community through the CEO Forum.

A Single Patient Story Can Define a Biotech Career Trajectory

Jodie Morrison's career was cemented by an early, powerful experience: witnessing a xenotransplant patient go from being wheelchair-bound to running a marathon. This direct link between research and profound human impact hooked her for life.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Biotech Needs Specialized 'Smoke Jumper' CEOs to Stabilize Companies in Crisis

Jodie Morrison defines her role as a 'smoke jumper,' a leader brought in specifically to stabilize an organization during a leadership change or crisis. This is a distinct skillset focused on immediate stabilization and team alignment.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Rising From Operations, Not Science, Can Create a More Holistic Biotech CEO

Jodie Morrison's path to CEO started from the bottom without a PhD or MD. This experience gave her a unique appreciation for all roles and levels, fostering an inclusive culture and a practical, operations-focused leadership style.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Even Experienced CEOs Felt Lost During the Pandemic, Highlighting the Job's Isolation

The CEO role is inherently lonely. During COVID-19, even a four-time CEO like Jodie Morrison had no idea what to do, which inspired her to create the CEO Forum to provide strength in numbers for a challenge no one had a playbook for.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

In Tough Markets, Prioritize a Single Lead Asset to Align with Investor Mentality

During capital-constrained periods, investors fixate on the single biggest value driver, usually a lead clinical asset. While platforms have value, companies must focus on the asset with the most compelling data to secure funding.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

A Turnaround CEO Should Evaluate Troubled Companies Like a 'Fixer-Upper' House

When assessing a company in crisis, look past the immediate mess to see if the 'bones are good'—meaning the core science or asset is sound. A strong foundation allows for a successful rebuild, regardless of surface-level chaos.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Major Biotech CEO Networks Often Emerge Organically from Immediate Crises

The 350+ member CEO Forum wasn't a planned initiative. It started during COVID-19 when Jodie Morrison created an email list for fellow Atlas Venture CEOs to share operational tactics, filling a sudden, urgent need for peer support.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Women Leaders in Biotech Have a Responsibility to 'Lift While We Climb'

Jodie Morrison argues it is not enough for women to achieve leadership positions; they have a duty to actively support and mentor the next generation. This involves giving back to the community and creating the support networks that didn't exist for them.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Biotech CEOs Can Use AI to Reclaim Time, Their Most Valuable Commodity

Beyond R&D, AI's immediate value for executives is operational efficiency. It can handle time-consuming tasks like drafting speeches or synthesizing competitive analyses, freeing leaders to focus on high-stakes strategic decisions.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago

Great CEOs Must Detach Emotionally from Beloved Assets and Teams to Make Tough Calls

Strategic decisions, especially painful ones like layoffs or shuttering a project, require removing personal emotion. A CEO's primary responsibility is to the company's strategic health and its investors, even when it conflicts with attachments.

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio thumbnail

Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Nucleate Podcast·2 months ago